Knight Therapeutics | GUD - Operating Expenses

Stock Price
7.66
Daily Change
0.21 2.82%
Monthly
23.55%
Yearly
34.62%
Q2 Forecast
7.26

Knight Therapeutics reported CAD126.9M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Acasti Pharma USD 62.82M 59.73M Sep/2025
Akebia Therapeutics USD 63.08M 8.26M Dec/2025
Alaunos Therapeutics USD 1.19M 148K Sep/2025
Aurora Cannabis CAD 129.98M 16.05M Dec/2025
Avita Medical AUD 28.02M 1.55M Dec/2025
Canopy Growth CAD 87.2M 6.22M Dec/2025
Cronos Group USD 51.59M 70.5M Dec/2025
Dianthus Therapeutics USD 69.82M 29.14M Dec/2025
Ionis Pharmaceuticals USD 418M 101.1M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Moderna USD 1.54B 259M Dec/2025
Omeros USD 59.16M 20.13M Jun/2024
Organigram Holdings CAD 83.66M 24.44M Dec/2025
Organon & Co USD 906M 362M Sep/2025
Revvity USD 626.22M 25.62M Dec/2025
Tectonic Therapeutic USD 21.52M 374K Dec/2025
Tilray USD 237.52M 17.34M Sep/2025
Viatris USD 3.86B 335.7M Dec/2025
Xeris Pharmaceuticals USD 69.03M 1.38M Dec/2025